Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
ResMed logo

ResMed Income Statement

Revenue, expenses, and profitability over time

ResMed generated $5.7B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $1.5B with a 26.8% net margin. Gross margin stands at 62.29% and operating margin at 34.47%. Diluted EPS is $10.36, which grew 0.1% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$5.5BGross Profit (TTM)$3.4BOperating Income (TTM)$1.9BNet Income (TTM)$1.5BEps Diluted (TTM)$10.37
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$27.9B
P/E Ratio18.41
ROE25.19%

Operating Expenses

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Depreciation and amortization$7.6M$7.4M$9.4M$7.8M$7.8M$7.9M
Amortization of acquired intangible assets$11M$10.9M$11.9M$12M$11.8M$11.2M

Other Income & Expense

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Income from equity method investments$1.1M$335K$1.3M$1.5M$1.5M$1.7M
Net investment gains (losses)-$1.4M-$5.6M-$2.5M-$6.2M$306K-$10.1M
Interest Income (Expense), Nonoperating-$775K$793K$5.8M$8.8M$7.9M$12.3M

Net Income

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Net income$344.6M$365M$379.7M$348.5M$392.6M$398.7M

Other

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Gain on insurance recoveries$0$0$0———
Income Taxes Paid, Net$118.6M—$16.2M$61.9M$147.5M$71.7M
Accounts payable and other current liabilities$4.2M$63.1M$49.1M$7.6M$10.6M$103.9M
Increase (Decrease) in Accounts Receivable$67.9M$40M$5.2M-$30M$72.7M$16.9M
Increase (Decrease) in Inventories$7.6M—$32.1M$14.7M-$26.1M-$12.5M
Increase (Decrease) in Prepaid Expense and Other Assets$43.6M-$79.4M-$47M-$2.3M$106.4M$48.3M
Interest Paid, Excluding Capitalized Interest, Operating Activity$0$14.2M$6.9M$6.9M$6.6M$6.5M
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation-$147.5M-$144.1M-$163.9M-$230.3M-$258.3M-$255.2M
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation-$36.7M-$31.8M-$133.7M-$52.6M-$50.9M-$58M
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation$308.6M$578.7M$538.8M$457.3M$339.7M$554.1M
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1$0$0$6.3M———
Payments for Repurchase of Common Stock$75M$75M$100M$150M$175M$175M
Payments of Dividends$77.7M$77.7M$77.6M$87.8M$87.6M$87.2M
Payment related to business acquisition$670K$0$138.6M$522K—$24.9M
Payments to Acquire Businesses, Net of Cash Acquired$670K$0$138.6M$522K—$24.9M
Payments to Acquire Intangible Assets-$1.8M$0$10.8M$2.8M——
Payments to Acquire Investments$1M$2.1M$2M$2.2M$4.2M$20.1M
Payments to Acquire Property, Plant, and Equipment$20.6M$20.8M$30.6M$43M$28.5M$33.7M
Proceeds from Issuance of Common Stock$26.9M$9M$30.2M$8.2M$29.6M$7.4M
Repayments of Long-Term Debt$5M$0$5M$0$5M—
Stock-based compensation$22.6M$24.1M$24.8M$21.2M$28.9M$26.8M

Revenue

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Debt and Equity Securities, Unrealized Gain (Loss)-$1.4M-$5.6M-$2.5M-$6.2M—-$10.1M